Change in quality of life in patients with relapsing-remitting multiple sclerosis over 2 years in relation to other clinical parameters: Results from a trial of intramuscular interferon β-1a

Multiple Sclerosis Journal

Volumn 17, Issue 6, 2011, Pages 734-742

  Miller, D M ^a   Weinstock Guttman, B ^b   Bourdette, D ^c   You, X ^d   Foulds, P ^d   Rudick, R A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b JACOBS NEUROLOGICAL INSTITUTE   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d BIOGEN   (United States)

Author keywords

interferon beta 1a; multiple sclerosis; quality of life; relapsing remitting multiple sclerosis; sickness impact profile

Indexed keywords

BETA1A INTERFERON;

ADULT; ARTICLE; BLADDER FUNCTION; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE COURSE; DISEASE DURATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG WITHDRAWAL; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; INTESTINE FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; PHYSICAL DISABILITY; PYRAMIDAL TRACT; QUALITY OF LIFE; RELAPSE; REMISSION; SICKNESS IMPACT PROFILE; VISION;

EID: 79959441293     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458510397221     Document Type: Article

References (31)

1. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med. 2000 ; 343: 938-952
2. Calabresi PA. Diagnosis and management of multiple sclerosis. Am Fam Physician. 2004 ; 70: 1935-1944 (Pubitemid 39532194)
3. Burden of illness of multiple sclerosis: Part II: Quality of life. Can J Neurol Sci. 1998 ; 25: 31-38
4. Rudick RA, Miller D, Hass S, et al. Health-related quality of life in multiple sclerosis: effects of natalizumab. Ann Neurol. 2007 ; 62: 335-346 (Pubitemid 350105948)
5. Nortvedt MW, Riise T, Myhr KM, Nyland HI. Quality of life in multiple sclerosis: measuring the disease effects more broadly. Neurology. 1999 ; 53: 1098-1103 (Pubitemid 29442130)
6. Hermann BP, Vickrey B, Hays RD, et al. A comparison of health-related quality of life in patients with epilepsy, diabetes and multiple sclerosis. Epilepsy Res. 1996 ; 25: 113-118 (Pubitemid 26298424)
7. Riazi A, Hobart JC, Lamping DL, et al. Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles. J Neurol Neurosurg Psychiatry. 2003 ; 74: 710-714 (Pubitemid 36628279)
8. Vermersch P, de Seze J, Delisse B, Lemaire S, Stojkovic T. Quality of life in multiple sclerosis: influence of interferon-beta1 a (Avonex) treatment. Mult Scler. 2002 ; 8: 377-381
9. Zivadinov R, Zorzon M, Tommasi MA, et al. A longitudinal study of quality of life and side effects in patients with multiple sclerosis treated with interferon beta-1a. J Neurol Sci. 2003 ; 216: 113-118 (Pubitemid 37371875)
10. Arnoldus JH, Killestein J, Pfennings LE, Jelles B, Uitdehaag BM, Polman CH. Quality of life during the first 6 months of interferon-beta treatment in patients with MS. Mult Scler. 2000 ; 6: 338-342
11. Simone IL, Ceccarelli A, Tortorella C, et al. Influence of Interferon beta treatment on quality of life in multiple sclerosis patients. Health Qual Life Outcomes. 2006 ; 4: 96-96
12. Lily O, McFadden E, Hensor E, Johnson M, Ford H. Disease-specific quality of life in multiple sclerosis: the effect of disease modifying treatment. Mult Scler. 2006 ; 12: 808-813 (Pubitemid 46111775)
13. Rice GP, Oger J, Duquette P, et al. Treatment with interferon beta-1b improves quality of life in multiple sclerosis. Can J Neurol Sci. 1999 ; 26: 276-282 (Pubitemid 29522812)
14. Jacobs LD, Cookfair DL, Rudick RA, et al. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Ann Neurol. 1996 ; 39: 285-294 (Pubitemid 26100751)
15. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care. 1981 ; 19: 787-805 (Pubitemid 11021288)
16. Freeman JA, Thompson AJ, Fitzpatrick R, et al. Interferon-beta1b in the treatment of secondary progressive MS: impact on quality of life. Neurology. 2001 ; 57: 1870-1875 (Pubitemid 33096697)
17. Miller DM, Rudick RA, Baier M, et al. Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis. Mult Scler. 2003 ; 9: 1-5 (Pubitemid 36253688)
18. Baier ML, Cutter GR, Rudick RA, et al. Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis. Neurology. 2005 ; 64: 992-995 (Pubitemid 40388449)
19. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983 ; 33: 1444-1452 (Pubitemid 14237132)
20. Jurkovich G, Mock C, MacKenzie E, et al. The Sickness Impact Profile as a tool to evaluate functional outcome in trauma patients. J Trauma. 1995 ; 39: 625-631
21. Whitaker JN, McFarland HF, Rudge P, Reingold SC. Outcomes assessment in multiple sclerosis clinical trials: a critical analysis. Mult Scler. 1995 ; 1: 37-47
22. Vickrey BG, Hays RD, Harooni R, Myers LW, Ellison GW. A health-related quality of life measure for multiple sclerosis. Qual Life Res. 1995 ; 4: 187-206
23. Peters TJ, Somerset M, Campbell R, Sharp DJ. Variables associated with attendance at, and the perceived helpfulness of, meetings for people with multiple sclerosis. Health Soc Care Community. 2003 ; 11: 19-26 (Pubitemid 38422514)
24. Mohr DC, Burke H, Beckner V, Merluzzi N. A preliminary report on a skills-based telephone-administered peer support programme for patients with multiple sclerosis. Mult Scler. 2005 ; 11: 222-226 (Pubitemid 40403263)
25. LaBan MM, Martin T, Pechur J, Sarnacki S. Physical and occupational therapy in the treatment of patients with multiple sclerosis. Phys Med Rehabil Clin N Am. 1998 ; 9: 603-614, vii (Pubitemid 28405508)
26. Patti F, Ciancio MR, Reggio E, et al. The impact of outpatient rehabilitation on quality of life in multiple sclerosis. J Neurol. 2002 ; 249: 1027-1033 (Pubitemid 35002224)
27. Rigby SA, Thornton EW, Young CA. A randomized group intervention trial to enhance mood and self-efficacy in people with multiple sclerosis. Br J Health Psychol. 2008 ; 13: 619-631
28. Walker ID, Gonzalez EW. Review of intervention studies on depression in persons with multiple sclerosis. Issues Ment Health Nurs. 2007 ; 28: 511-531
29. Thomas PW, Thomas S, Hillier C, Galvin K, Baker R. Psychological interventions for multiple sclerosis. Cochrane Database Syst Rev. 2006 ;: CD004431 - CD004431
30. Malcomson KS, Dunwoody L, Lowe-Strong AS. Psychosocial interventions in people with multiple sclerosis: a review. J Neurol. 2007 ; 254: 1-13 (Pubitemid 46295082)
31. Scmid W, Aldridge D. Active music therapy in the treatment of multiple sclerosis patients: a matched control group. J Music Ther. 2004 ; 41: 225-240 (Pubitemid 39234343)